Search for: "DaVita, Inc." Results 1 - 20 of 76
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Feb 2023, 3:10 pm by Rob Robinson
Editor’s Note: From time to time, ComplexDiscovery highlights publicly available or privately purchasable announcements, content updates, and research from cyber, data, and legal discovery providers, research organizations, and ComplexDiscovery community members. [read post]
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
Similarly, the FTC also issued an order against DaVita, Inc., a dialysis services provider, forcing it to divest itself of certain dialysis clinics it had acquired and give them to a competing provider company. [read post]
21 Jun 2022, 8:46 am by Ronald Mann
DaVita Inc. laid out a roadmap for private insurers to shift the costs of end-stage renal disease to Medicare, as the court approved a private health plan that singles out the provision of outpatient dialysis for low reimbursement, a plan likely to push those patients out of the private market and onto Medicare. [read post]
23 May 2022, 9:01 pm by Karen Hoffman Lent and Kenneth Schwartz
Since the Spring Meeting, however, the DOJ’s attempts to bring cases under such novel theories have failed in two separate actions: the DaVita, Inc. no-poach case, and the Jindal wage-fixing allegation. [read post]
20 Apr 2022, 6:18 am by Katherine Witherspoon Fry, Esq.
  In the first-ever criminal trial for labor-related antitrust (Sherman Act) violations, the Department of Justice alleges that former DaVita Inc. [read post]
20 Apr 2022, 6:18 am by Katherine Witherspoon Fry, Esq.
  In the first-ever criminal trial for labor-related antitrust (Sherman Act) violations, the Department of Justice alleges that former DaVita Inc. [read post]
9 Mar 2022, 2:06 pm by Kevin LaCroix
  The largest 2021 settlements included one settlement in excess of $1 billion (the $1.21 billion settlement in the Valeant Pharmaceuticals International case) and four in excess of $100 million (Snap, Inc.: $187.5 million; DaVita, Inc.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
2 Mar 2022, 12:45 pm by Ronald Mann
DaVita Inc. offered no surprises, as the justices grappled with the financial ramifications of applying a vaguely written statute to an insurer’s craftily designed arrangement for lowering the reimbursements it pays for outpatient dialysis. [read post]